Ki Summary

Reaction Details

Report a problem with these data

Target

Gastric inhibitory polypeptide

Ligand

BDBM50244337

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_491828 (CHEMBL945218)

IC50

3000±n/a nM

Citation

Kim, RM; Chang, J; Lins, AR; Brady, E; Candelore, MR; Dallas-Yang, Q; Ding, V; Dragovic, J; Iliff, S; Jiang, G; Mock, S; Qureshi, S; Saperstein, R; Szalkowski, D; Tamvakopoulos, C; Tota, L; Wright, M; Yang, X; Tata, JR; Chapman, K; Zhang, BB; Parmee, ER Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett18:3701-5 (2008) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Gastric inhibitory polypeptide

Name:

Gastric inhibitory polypeptide

Synonyms:

GIP | GIP_HUMAN

Type:

PROTEIN

Mol. Mass.:

17110.38

Organism:

Homo sapiens (Human)

Description:

ChEMBL_491828

Residue:

153

Sequence:

MVATKTFALLLLSLFLAVGLGEKKEGHFSALPSLPVGSHAKVSSPQPRGPRYAEGTFISD
YSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQREARALELASQANRKEEEAVEPQSSPA
KNPSDEDLLRDLLIQELLACLLDQTNLCRLRSR

BDBM50244337

n/a

Name

BDBM50244337

Synonyms:

CHEMBL511964 | trans-4-(((4-tert-butylcyclohexyl)(5,6-dichloro-1-methyl-1H-benzo[d]imidazol-2-yl)amino)methyl)-N-(1H-tetrazol-5-yl)benzamide

Type

Small organic molecule

Emp. Form.

C27H32Cl2N8O

Mol. Mass.

555.502

SMILES

Cn1c(nc2cc(Cl)c(Cl)cc12)N(Cc1ccc(cc1)C(=O)Nc1nnn[nH]1)[C@H]1CC[C@@H](CC1)C(C)(C)C |r,wU:28.31,wD:31.38,(37.8,-49.39,;38.58,-48.06,;40,-47.47,;39.88,-45.93,;38.38,-45.58,;37.65,-44.23,;36.11,-44.19,;35.37,-42.84,;35.31,-45.51,;33.77,-45.47,;36.05,-46.85,;37.58,-46.89,;41.33,-48.24,;41.33,-49.78,;42.66,-50.56,;43.99,-49.79,;45.31,-50.57,;45.31,-52.11,;43.96,-52.87,;42.64,-52.09,;46.64,-52.89,;46.63,-54.43,;47.97,-52.13,;49.3,-52.91,;49.82,-54.36,;51.36,-54.32,;51.8,-52.84,;50.53,-51.97,;42.66,-47.48,;42.67,-45.94,;44.01,-45.19,;45.34,-45.97,;45.32,-47.51,;43.99,-48.26,;46.68,-45.21,;48,-44.43,;47.45,-46.54,;45.92,-43.87,)|

Structure